Search

Your search keyword '"Evans, D. G."' showing total 37 results

Search Constraints

Start Over You searched for: Author "Evans, D. G." Remove constraint Author: "Evans, D. G." Topic genetic predisposition to disease Remove constraint Topic: genetic predisposition to disease
37 results on '"Evans, D. G."'

Search Results

1. Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing.

2. Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers.

4. Genetic testing in a cohort of young patients with HER2-amplified breast cancer.

5. Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.

6. Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UK.

7. Mutation type and position varies between mosaic and inherited NF2 and correlates with disease severity.

8. Reproductive decision-making in young female carriers of a BRCA mutation.

9. Metachronous colorectal cancer risk in patients with a moderate family history.

10. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.

11. Breast cancer susceptibility variants alter risk in familial ovarian cancer.

12. RASSF1A polymorphism in familial breast cancer.

13. Childhood predictive genetic testing for Li-Fraumeni syndrome.

14. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

15. Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3.

16. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

17. Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up.

18. Familial colorectal cancer referral to regional genetics department--a single centre experience.

19. Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.

20. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

21. Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.

22. Cancer genetics service provision: a comparison of seven European centres.

23. Risk assessment and management of high risk familial breast cancer.

24. Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort.

25. A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients.

26. Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.

27. Identification of the familial cylindromatosis tumour-suppressor gene.

28. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG).

29. Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.

30. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?

31. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

32. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

33. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

34. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

35. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

36. The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS)

37. Correction:Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

Catalog

Books, media, physical & digital resources